|
Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes
|
Oct 2014
|
Biol Blood Marrow Transplant
|
myelodysplastic syndromes (MDS)
|
|
Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria
|
Apr 2012
|
BioDrugs
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Unveiling the paradoxical nature of myelodysplastic syndromes (MDS): Why hypercellular marrow strongly favors accelerated apoptosis.
|
Mar 2013
|
Biochem Cell Biol
|
myelodysplastic syndromes (MDS)
|
|
Clonal Hematopoiesis and therapy related MDS/AML
|
Mar 2019
|
Best Practice & Research. Clinical Heamatology
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic/myeloproliferative Neoplasm, Unclassifiable (MDS/MPN-U): More Than Just a "Catch-All" Term?
|
Jun 2020
|
Best practice & research. Clinical haematology
|
myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
|
|
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading?
|
Dec 2020
|
Best practice & research. Clinical haematology
|
myelodysplastic syndromes (MDS)
|
|
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality?
|
May 2020
|
Best practice & research. Clinical haematology
|
myelodysplastic syndromes (MDS)
|
|
MDS/MPN-RS-T Justified Inclusion as a Unique Disease Entity?
|
Jun 2020
|
Best practice & research. Clinical haematology
|
myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
|
|
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality?
|
Jun 2020
|
Best practice & research. Clinical haematology
|
myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
|
|
Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes?
|
Dec 2012
|
Best Pract Res Clin Haematol
|
myelodysplastic syndromes (MDS)
|
